Stryker sees FY26 adjusted EPS $14.90-$15.10, consensus $14.94

Stryker (SYK) said, “Based on our momentum exiting 2025, healthy procedural volumes and strong demand for our capital products, we expect 2026 organic net sales growth to be in the range of 8.0% to 9.5% and adjusted net earnings per diluted share to be in the range of $14.90 to $15.10. Our full year sales guidance includes a modestly favorable pricing impact. Additionally, foreign exchange is expected to have a slightly positive impact on both sales and adjusted net earnings per diluted share should rates hold near year-to-date levels.”